The new surgical method, called NeuroSAFE, preserves the nerves that run through the prostate’s outer layers, which are ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

The FDA approved a radioligand therapy for earlier use prior to chemotherapy in patients with prostate-specific membrane ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers ...

The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

Dr. Dan Sperling As a radiologist specializing in prostate cancer diagnosis and treatment, I’m writing to share a fear I often hear from my patients. “Will this treatment affect my sex life?” This ...

According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.